KRONOS WORLDWIDE INC (KRO) Fundamental Analysis & Valuation

NYSE:KRO • US50105F1057

5.78 USD
0 (0%)
Last: Mar 5, 2026, 02:20 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This KRO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

KRO gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 83 industry peers in the Chemicals industry. The financial health of KRO is average, but there are quite some concerns on its profitability. KRO is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. KRO Profitability Analysis

1.1 Basic Checks

  • KRO had negative earnings in the past year.
  • In the past year KRO has reported a negative cash flow from operations.
  • Of the past 5 years KRO 4 years were profitable.
  • In the past 5 years KRO always reported a positive cash flow from operatings.
KRO Yearly Net Income VS EBIT VS OCF VS FCFKRO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

1.2 Ratios

  • The Return On Assets of KRO (-2.16%) is worse than 60.24% of its industry peers.
  • KRO's Return On Equity of -5.13% is on the low side compared to the rest of the industry. KRO is outperformed by 60.24% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 2.68%, KRO is in line with its industry, outperforming 44.58% of the companies in the same industry.
Industry RankSector Rank
ROA -2.16%
ROE -5.13%
ROIC 2.68%
ROA(3y)2.41%
ROA(5y)3.2%
ROE(3y)5.13%
ROE(5y)7.28%
ROIC(3y)N/A
ROIC(5y)N/A
KRO Yearly ROA, ROE, ROICKRO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

  • In the last couple of years the Profit Margin of KRO has declined.
  • The Operating Margin of KRO (2.97%) is worse than 63.86% of its industry peers.
  • KRO's Operating Margin has declined in the last couple of years.
  • The Gross Margin of KRO (16.25%) is worse than 73.49% of its industry peers.
  • KRO's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.97%
PM (TTM) N/A
GM 16.25%
OM growth 3Y-12.41%
OM growth 5Y-5.03%
PM growth 3Y-7.77%
PM growth 5Y-1.91%
GM growth 3Y-6.11%
GM growth 5Y-3.12%
KRO Yearly Profit, Operating, Gross MarginsKRO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. KRO Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), KRO is destroying value.
  • Compared to 1 year ago, KRO has about the same amount of shares outstanding.
  • The number of shares outstanding for KRO has been reduced compared to 5 years ago.
  • The debt/assets ratio for KRO is higher compared to a year ago.
KRO Yearly Shares OutstandingKRO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
KRO Yearly Total Debt VS Total AssetsKRO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • Based on the Altman-Z score of 1.74, we must say that KRO is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of KRO (1.74) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.78 indicates that KRO is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.78, KRO perfoms like the industry average, outperforming 44.58% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Altman-Z 1.74
ROIC/WACC0.23
WACC11.79%
KRO Yearly LT Debt VS Equity VS FCFKRO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 3.83 indicates that KRO has no problem at all paying its short term obligations.
  • KRO's Current ratio of 3.83 is amongst the best of the industry. KRO outperforms 90.36% of its industry peers.
  • KRO has a Quick Ratio of 1.47. This is a normal value and indicates that KRO is financially healthy and should not expect problems in meeting its short term obligations.
  • KRO has a Quick ratio of 1.47. This is in the better half of the industry: KRO outperforms 61.45% of its industry peers.
Industry RankSector Rank
Current Ratio 3.83
Quick Ratio 1.47
KRO Yearly Current Assets VS Current LiabilitesKRO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. KRO Growth Analysis

3.1 Past

  • The earnings per share for KRO have decreased strongly by -244.00% in the last year.
  • Measured over the past years, KRO shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -24.83% on average per year.
  • Looking at the last year, KRO shows a small growth in Revenue. The Revenue has grown by 0.01% in the last year.
  • KRO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.74% yearly.
EPS 1Y (TTM)-244%
EPS 3Y-43.16%
EPS 5Y-24.83%
EPS Q2Q%-633.33%
Revenue 1Y (TTM)0.01%
Revenue growth 3Y-0.91%
Revenue growth 5Y1.74%
Sales Q2Q%-5.74%

3.2 Future

  • Based on estimates for the next years, KRO will show a very strong growth in Earnings Per Share. The EPS will grow by 39.61% on average per year.
  • The Revenue is expected to grow by 0.80% on average over the next years.
EPS Next Y-335.67%
EPS Next 2Y-39.61%
EPS Next 3Y39.61%
EPS Next 5YN/A
Revenue Next Year-12.6%
Revenue Next 2Y-4.19%
Revenue Next 3Y0.8%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
KRO Yearly Revenue VS EstimatesKRO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
KRO Yearly EPS VS EstimatesKRO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

1

4. KRO Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for KRO. In the last year negative earnings were reported.
  • A Price/Forward Earnings ratio of 88.04 indicates a quite expensive valuation of KRO.
  • KRO's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. KRO is more expensive than 67.47% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 25.11. KRO is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 88.04
KRO Price Earnings VS Forward Price EarningsKRO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as KRO.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.38
KRO Per share dataKRO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • KRO's earnings are expected to grow with 39.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-39.61%
EPS Next 3Y39.61%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. KRO Dividend Analysis

5.1 Amount

  • KRO has a Yearly Dividend Yield of 3.54%.
  • Compared to an average industry Dividend Yield of 2.19, KRO pays a better dividend. On top of this KRO pays more dividend than 81.93% of the companies listed in the same industry.
  • KRO's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.54%

5.2 History

  • The dividend of KRO decreases each year by -7.80%.
  • KRO has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-7.8%
Div Incr Years0
Div Non Decr Years0
KRO Yearly Dividends per shareKRO Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

  • The earnings of KRO are negative and hence is the payout ratio. KRO will probably not be able to sustain this dividend level.
DP-55.69%
EPS Next 2Y-39.61%
EPS Next 3Y39.61%
KRO Yearly Income VS Free CF VS DividendKRO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

More info and screens

Find the best dividend stocksShow peers with best dividend

KRO Fundamentals: All Metrics, Ratios and Statistics

KRONOS WORLDWIDE INC

NYSE:KRO (3/5/2026, 2:20:59 PM)

5.78

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-06
Earnings (Next)03-09
Inst Owners16.83%
Inst Owner Change-5.69%
Ins Owners0.17%
Ins Owner Change0%
Market Cap664.99M
Revenue(TTM)1.86B
Net Income(TTM)-41.30M
Analysts46.67
Price Target5.61 (-2.94%)
Short Float %7.48%
Short Ratio5.09
Dividend
Industry RankSector Rank
Dividend Yield 3.54%
Yearly Dividend0.48
Dividend Growth(5Y)-7.8%
DP-55.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-293.36%
Min EPS beat(2)-428.05%
Max EPS beat(2)-158.67%
EPS beat(4)0
Avg EPS beat(4)-195.61%
Min EPS beat(4)-428.05%
Max EPS beat(4)-6.81%
EPS beat(8)3
Avg EPS beat(8)-2%
EPS beat(12)3
Avg EPS beat(12)-62.91%
EPS beat(16)6
Avg EPS beat(16)-38.64%
Revenue beat(2)0
Avg Revenue beat(2)-3.64%
Min Revenue beat(2)-4.26%
Max Revenue beat(2)-3.02%
Revenue beat(4)0
Avg Revenue beat(4)-6.45%
Min Revenue beat(4)-15.25%
Max Revenue beat(4)-3.02%
Revenue beat(8)2
Avg Revenue beat(8)-5.34%
Revenue beat(12)4
Avg Revenue beat(12)-2.96%
Revenue beat(16)7
Avg Revenue beat(16)-1.72%
PT rev (1m)0%
PT rev (3m)-18.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-390%
EPS NY rev (1m)0%
EPS NY rev (3m)-1300%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.17%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.4%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 88.04
P/S 0.36
P/FCF N/A
P/OCF N/A
P/B 0.83
P/tB 0.83
EV/EBITDA 11.38
EPS(TTM)-0.36
EYN/A
EPS(NY)0.07
Fwd EY1.14%
FCF(TTM)-0.74
FCFYN/A
OCF(TTM)-0.35
OCFYN/A
SpS16.2
BVpS6.99
TBVpS6.97
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.16%
ROE -5.13%
ROCE 3.39%
ROIC 2.68%
ROICexc 2.73%
ROICexgc 2.73%
OM 2.97%
PM (TTM) N/A
GM 16.25%
FCFM N/A
ROA(3y)2.41%
ROA(5y)3.2%
ROE(3y)5.13%
ROE(5y)7.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-13.41%
ROICexgc growth 5Y-3.71%
ROICexc growth 3Y-13.47%
ROICexc growth 5Y-3.75%
OM growth 3Y-12.41%
OM growth 5Y-5.03%
PM growth 3Y-7.77%
PM growth 5Y-1.91%
GM growth 3Y-6.11%
GM growth 5Y-3.12%
F-Score3
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Debt/EBITDA 5.64
Cap/Depr 80.79%
Cap/Sales 2.41%
Interest Coverage 1.08
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.83
Quick Ratio 1.47
Altman-Z 1.74
F-Score3
WACC11.79%
ROIC/WACC0.23
Cap/Depr(3y)89.54%
Cap/Depr(5y)98.19%
Cap/Sales(3y)2.56%
Cap/Sales(5y)2.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-244%
EPS 3Y-43.16%
EPS 5Y-24.83%
EPS Q2Q%-633.33%
EPS Next Y-335.67%
EPS Next 2Y-39.61%
EPS Next 3Y39.61%
EPS Next 5YN/A
Revenue 1Y (TTM)0.01%
Revenue growth 3Y-0.91%
Revenue growth 5Y1.74%
Sales Q2Q%-5.74%
Revenue Next Year-12.6%
Revenue Next 2Y-4.19%
Revenue Next 3Y0.8%
Revenue Next 5YN/A
EBIT growth 1Y-36.36%
EBIT growth 3Y-13.2%
EBIT growth 5Y-3.37%
EBIT Next Year-56.35%
EBIT Next 3Y9.68%
EBIT Next 5YN/A
FCF growth 1Y12.24%
FCF growth 3Y-33.75%
FCF growth 5Y-16.38%
OCF growth 1Y-11.02%
OCF growth 3Y-29.45%
OCF growth 5Y-14.67%

KRONOS WORLDWIDE INC / KRO FAQ

What is the ChartMill fundamental rating of KRONOS WORLDWIDE INC (KRO) stock?

ChartMill assigns a fundamental rating of 3 / 10 to KRO.


Can you provide the valuation status for KRONOS WORLDWIDE INC?

ChartMill assigns a valuation rating of 1 / 10 to KRONOS WORLDWIDE INC (KRO). This can be considered as Overvalued.


How profitable is KRONOS WORLDWIDE INC (KRO) stock?

KRONOS WORLDWIDE INC (KRO) has a profitability rating of 2 / 10.


How financially healthy is KRONOS WORLDWIDE INC?

The financial health rating of KRONOS WORLDWIDE INC (KRO) is 4 / 10.


What is the earnings growth outlook for KRONOS WORLDWIDE INC?

The Earnings per Share (EPS) of KRONOS WORLDWIDE INC (KRO) is expected to decline by -335.67% in the next year.